PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 57.15
-1.65 (-2.81%)
At close: Mar 27, 2026
PegBio Statistics
Total Valuation
PegBio has a market cap or net worth of HKD 22.35 billion. The enterprise value is 21.87 billion.
| Market Cap | 22.35B |
| Enterprise Value | 21.87B |
Important Dates
The last earnings date was Monday, March 23, 2026.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PegBio has 391.09 million shares outstanding. The number of shares has increased by 3.19% in one year.
| Current Share Class | 284.30M |
| Shares Outstanding | 391.09M |
| Shares Change (YoY) | +3.19% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 24.20% |
| Owned by Institutions (%) | 22.95% |
| Float | 113.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 44.77 |
| P/TBV Ratio | 44.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -94.34 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.21.
| Current Ratio | 3.94 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.09 |
Financial Efficiency
Return on equity (ROE) is -82.42% and return on invested capital (ROIC) is -36.71%.
| Return on Equity (ROE) | -82.42% |
| Return on Assets (ROA) | -31.48% |
| Return on Invested Capital (ROIC) | -36.71% |
| Return on Capital Employed (ROCE) | -44.94% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.00M |
| Employee Count | 58 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 62.42 |
| 200-Day Moving Average | 47.05 |
| Relative Strength Index (RSI) | 44.42 |
| Average Volume (20 Days) | 695,858 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -229.12M |
| Pretax Income | -232.07M |
| Net Income | -231.87M |
| EBITDA | -228.15M |
| EBIT | -229.12M |
| Earnings Per Share (EPS) | -0.61 |
Balance Sheet
The company has 580.90 million in cash and 104.17 million in debt, with a net cash position of 476.74 million or 1.22 per share.
| Cash & Cash Equivalents | 580.90M |
| Total Debt | 104.17M |
| Net Cash | 476.74M |
| Net Cash Per Share | 1.22 |
| Equity (Book Value) | 499.20M |
| Book Value Per Share | 1.29 |
| Working Capital | 462.07M |
Cash Flow
| Operating Cash Flow | -169.04M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 994,972 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PegBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.19% |
| Shareholder Yield | -3.19% |
| Earnings Yield | -1.04% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |